Viewing StudyNCT04478357



Ignite Creation Date: 2024-05-06 @ 2:57 PM
Last Modification Date: 2024-10-26 @ 1:40 PM
Study NCT ID: NCT04478357
Status: COMPLETED
Last Update Posted: 2021-05-07
First Post: 2020-07-01

Brief Title: BIOEQUIVALENCE STUDY IN HEALTHY PARTICIPANTS COMPARING 4 MG AND 8 MG FESOTERODINE EXTENDED-RELEASE TABLETS TOVIAZ MANUFACTURED AT ZWICKAU VERSUS FREIBURG
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Neurogenic Detrusor Overactivity
Keywords:
Name View
Toviaz View
Phase I View
Fesoterodine beads- in-capsule View
bioequivalence View
Pharmacokinetics View